Navigation Links
Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2008
Date:1/28/2009

om divested businesses of $553 million.

Worldwide sales of the Company's CRM products for the full year were as follows:


    (in millions)             U.S.        International        Worldwide
                         2008      2007  2008       2007    2008       2007
    ICD systems        $1,140    $1,053  $541       $489  $1,681     $1,542
    Pacemaker systems     340       318   265        264     605        582

    Total CRM products $1,480    $1,371  $806       $753  $2,286     $2,124

Worldwide sales of the Company's coronary stent systems for the full year were as follows:


    (in millions)               U.S.        International        Worldwide
                           2008      2007  2008       2007    2008       2007
    Drug-eluting           $833    $1,006  $801       $782  $1,634     $1,788
    Bare-metal               88       104   129        135     217        239

    Total coronary stent
     systems               $921    $1,110  $930       $917  $1,851     $2,027

Reported net loss for 2008 was $2.072 billion, or $1.38 per share. Reported results for 2008 included intangible asset impairments, acquisition-, divestiture-, litigation- and restructuring-related charges, and amortization expense (after-tax) of $3.289 billion, or $2.19 per share, which consisted of:

  • $2.810 billion ($2.844 billion pre-tax) of intangible asset impairment charges, associated primarily with a write-down of goodwill;
  • a $184 million gain ($250 million pre-tax) related to the receipt of an acquisition-related milestone payment from Abbott Laboratories;
  • $44 million ($43 million pre-tax) of net purchased research and development charges, associated primarily with the Company's acquisitions of CryoCor, Inc. and Labcoat, Ltd.;
  • $100 million of charges ($133 million p
    '/>"/>

SOURCE Boston Scientific Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

Related medicine news :

1. Boston Scientific and Medtronic Reach Agreement on Patent Disputes
2. Its Cold Outside! Warm Up in Select Downtown Boston Heated Bus Shelters Courtesy of TYLENOL(r) Warming Liquids
3. Boston Scientific Awarded CRM Contract by Department of Veterans Affairs
4. BioMed Realty Trusts Center for Life Science Boston Now 91% Leased
5. Boston Scientific Announces Court Decision
6. Boston Scientific to Webcast Conference Call Discussing Fourth Quarter and 2008 Financial Results
7. Boston Scientific to Participate in JP Morgan Health Care Conference
8. Boston Hyundai Dealer Teams up With the Red Cross to Save Lives
9. BMC, Boston University School of Medicine dermatologist named one of Americas Top Doctors
10. BMC, Boston University School of Medicine cardiologist named 1 of Americas Top Doctors
11. Boston University Medical Center gynecologist named one of Americas top doctors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... ... July 31, 2015 , ... Ticket Down is a reputable source of authentic USA vs. ... will face the Australia Women's National Team in conjunction with their Victory Tour to celebrate ... Carli Lloyd from the USA team was awarded the Golden Ball as the best player ...
(Date:7/31/2015)... ... July 31, 2015 , ... Eldermark ... for LeadingAge’s Center for Aging Services Technologies (CAST) Medication Management Technologies whitepaper. The ... post-acute care providers understand the benefits of using medication management technologies . ...
(Date:7/31/2015)... ... July 31, 2015 , ... ZH Healthcare announces a ... , What is HITaaS? Health IT as a Service (HITaaS) is a Healthcare dedicated ... a service (SaaS). , HITaaS manages all aspects of infrastructure, security, ...
(Date:7/31/2015)... York (PRWEB) , ... July 31, 2015 , ... Physical therapy for ... limits the patient's quality of life. It keeps the patient from doing what they want ... and may have a hard time using the stairs. The patient's exercise regime may be ...
(Date:7/31/2015)... ... July 31, 2015 , ... New Energy Works Timberframers invites the public to ... August 15th, 2015 from 9am – 12pm. Timber frame raisings are special, ... entire community as the culmination of months of effort, planning, fundraising, and dreaming takes ...
Breaking Medicine News(10 mins):Health News:Cheap USA vs. Australia Tickets at Ford Field in Detroit, MI: Ticket Down Slashes Ticket Prices for Australia vs. USWNT International Friendly Match at Ford Field 2Health News:LeadingAge Selects Eldermark Case Study to Highlight Medication Error Reduction Results 2Health News:LeadingAge Selects Eldermark Case Study to Highlight Medication Error Reduction Results 3Health News:ZH Healthcare Unveils Health IT as a Service (HITaaS) at OSEHRA 2015 2Health News:ZH Healthcare Unveils Health IT as a Service (HITaaS) at OSEHRA 2015 3Health News:ZH Healthcare Unveils Health IT as a Service (HITaaS) at OSEHRA 2015 4Health News:NYDNRehab Is the First Clinic in NYC to Provide APOS Therapy Based on Results of Complete Gait Analysis 2Health News:NYDNRehab Is the First Clinic in NYC to Provide APOS Therapy Based on Results of Complete Gait Analysis 3Health News:Timber Frame Raising: Granary District Stage Amphitheater Timber Frame Hand-Raising by New Energy Works Timberframers 2Health News:Timber Frame Raising: Granary District Stage Amphitheater Timber Frame Hand-Raising by New Energy Works Timberframers 3
... * concentrated Tylenol(R) Infants, Drops Plus ... * PediaCare(R) ... Consumer,Healthcare, a division of McNeil-PPC, Inc., announced today that the,company is ... used as directed, these medicines are generally,recognized as safe and effective. ...
... 11 ALOKA Co., Ltd., a pioneer in ... of Masanobu Tada as President, and Carlos Faustmann ... AG, the company,s,wholly-owned European headquarters in Zug, Switzerland, ... the Global Marketing of the company as,general manager ...
... Passage of Plan to Give Access to Affordable Health ... week after Cover,All Pennsylvanians, the centerpiece of his "Prescription ... Rendell today held a,town meeting in Erie as part ... will highlight the need to lower health care costs,and ...
... virus (MMTV) - which causes mammary cancer in mice - ... week shows. The study, published in the online open access ... be involved in causing human breast cancer. , The idea ... around for over 50 years. In the 1990s, researchers detected ...
... Avicena Group,Inc. (OTC Bulletin Board: AVGO), a late-stage ... neurodegenerative,disorders, announced today the appointment of its C.E.O., ... of the Company,s,Board of the Directors. Dr. Tsao- ... Board to focus his time on other business,ventures. ...
... 10 HealthShares(TM) Inc., an investment,company with a family ... has approved the transfer of its 19 currently NYSE-listed,HealthShares ... accordance with NYSE Euronext requirement to transfer of all ... expected to be completed prior to,October 31, 2007. The ...
Cached Medicine News:Health News:McNeil Consumer Healthcare is Voluntarily Withdrawing Infants' Cough and Cold Products: 2Health News:McNeil Consumer Healthcare is Voluntarily Withdrawing Infants' Cough and Cold Products: 3Health News:ALOKA Appoints New Management in Europe 2Health News:Governor Rendell Launches 'Tour to Insure' In Erie; 2Health News:Governor Rendell Launches 'Tour to Insure' In Erie; 3Health News:Mouse mammary tumor virus can replicate in human cells 2Health News:Avicena Appoints Dr. Belinda Tsao-Nivaggioli as Chairman of the Board of Directors 2Health News:XShares Group LLC to Begin the Transfer of HealthShares(TM) NYSE-Listed ETFs to NYSE Arca 2Health News:XShares Group LLC to Begin the Transfer of HealthShares(TM) NYSE-Listed ETFs to NYSE Arca 3Health News:XShares Group LLC to Begin the Transfer of HealthShares(TM) NYSE-Listed ETFs to NYSE Arca 4
(Date:7/31/2015)... HYDERABAD, India , July 31, 2015 /PRNewswire/ ... Billing and CRM solutions for video, data and cloud ... (PoC) with a leading pharma giant for Internet ... managing different IoT applications offered on subscription model. ... Pharma giant is striving for business ...
(Date:7/30/2015)... DIEGO , July 30, 2015 /PRNewswire/ ... it has signed a definitive agreement to ... of non-invasive ventilation and sleep-disordered breathing medical ... clinical, innovation and market reputation in China, combined with ResMed,s global leadership in ... people in China ...
(Date:7/30/2015)... 2015  Tandem Diabetes Care®, Inc. (NASDAQ: ... of the t:slim® and t:flex™ Insulin Pumps, today ... Agreements with Dexcom, Inc. to allow the integration ... Dexcom G5 and G6 continuous glucose monitoring ("CGM") ... platform with Dexcom,s future CGM systems is an ...
Breaking Medicine Technology:Magnaquest Signs a POC With a Leading Pharma Giant in Europe to Manage Subscription Management and Billing for Internet of Things (IoT) 2ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 2ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 3Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 2Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 3
... , , , , ... i c , Inc. (Nasdaq: ... medical imaging systems and surgical products dedicated to serving the healthcare needs ... study evaluating the impact of fetal fibronectin (fFN) testing among both symptomatic ...
... VIENNA, Va., Aug. 18 CEL-SCI Corporation (NYSE Amex: ... of its work towards creating a novel treatment and vaccination against ... in which the virus has acquired greater morbidity and mortality. ... are highly conserved and essential for the virus, survival. This ...
Cached Medicine Technology:Study Links Fetal Fibronectin Testing with Changes in Management Decisions for Symptomatic and Asymptomatic Women at Risk for Preterm Birth 2Study Links Fetal Fibronectin Testing with Changes in Management Decisions for Symptomatic and Asymptomatic Women at Risk for Preterm Birth 3Study Links Fetal Fibronectin Testing with Changes in Management Decisions for Symptomatic and Asymptomatic Women at Risk for Preterm Birth 4CEL-SCI Expands H1N1 Flu Virus Work 2CEL-SCI Expands H1N1 Flu Virus Work 3
For the quantitative in vitro determination of Microalbumin in human urine....
Determination of Reptilase Time.Extracted venom of Bothrops atrox. 20 BU (Batroxobin unit) per vial....
Quantitative determination of Fibrinogen by STA Analyzers (Clauss Method). Freeze-dried human thrombin (~100NIH units/mL) with heparin inhibitor and calcium....
Determination of Activated Partial Thromboplastin Time (APTT) by STA Analyzers. Cephalin reagent with particulate (silica) activator....
Medicine Products: